Spyre Therapeutics, Inc.

NASDAQ (USD): Spyre Therapeutics, Inc. (SYRE)

Last Price

32.00

Today's Change

-0.975 (2.95%)

Day's Change

31.74 - 33.47

Trading Volume

97,611

Overview

Market Cap

1 Billion

Shares Outstanding

51 Million

Avg Volume

500,659

Avg Price (50 Days)

31.25

Avg Price (200 Days)

31.19

PE Ratio

2.94

EPS

10.89

Earnings Announcement

27-Feb-2025

Previous Close

32.98

Open

33.03

Day's Range

31.7448 - 33.47

Year Range

8.75 - 47.97

Trading Volume

97,631

Price Change Highlight

1 Day Change

-2.96%

5 Day Change

-10.78%

1 Month Change

4.39%

3 Month Change

29.42%

6 Month Change

-18.54%

Ytd Change

49.56%

1 Year Change

197.72%

3 Year Change

-82.19%

5 Year Change

-83.69%

10 Year Change

-86.90%

Max Change

-86.90%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. The company's pipeline includes extended half-life antibodies targeting a4ß7, TL1A, and IL-23. The company was formerly known as Aeglea BioTherapeutics, Inc. and changed its name to Spyre Therapeutics, Inc. in November 2023. Spyre Therapeutics, Inc. was founded in 2013 and is based in Waltham, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment